AP
USNA icon

Anchyra Partners’s Usana Health Sciences USNA Stock Holding History

Anchyra Partners’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$230K Buy
+10,784
New +$203K 0.06% 287

Other funds holding USNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Anchyra Partners's USNA Position: Q2 2026 in Review

Anchyra Partners opened a new position in Usana Health Sciences (USNA) in Q2 2026: 10,784 shares worth $230K. The stake represents 0.06% of the portfolio and ranks #287 among its holdings.

137 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Anchyra Partners held 10,784 shares of Usana Health Sciences worth $230K as of Q2 2026.
  • Usana Health Sciences was a new Anchyra Partners position in Q2 2026.
  • Usana Health Sciences made up 0.06% of Anchyra Partners's portfolio in Q2 2026, its #287 holding.
  • 137 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Anchyra Partners's 13F filing for Q2 2026, filed 23 Jul 2026.